PEMETREXED is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Pemetrexed Disodium.
Product ID | 0409-1045_c3938f61-1af2-4c1b-9a0c-2d31e217997d |
NDC | 0409-1045 |
Product Type | Human Prescription Drug |
Proprietary Name | PEMETREXED |
Generic Name | Pemetrexed |
Dosage Form | Injection, Solution, Concentrate |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2022-06-27 |
Marketing Category | NDA / |
Application Number | NDA214218 |
Labeler Name | Hospira, Inc. |
Substance Name | PEMETREXED DISODIUM |
Active Ingredient Strength | 100 mg/4mL |
Pharm Classes | Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-06-27 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0338-0720 | PEMETREXED | PEMETREXED |
0338-0722 | PEMETREXED | PEMETREXED |
0409-1045 | PEMETREXED | PEMETREXED |
0409-1060 | Pemetrexed | Pemetrexed |
0409-1061 | Pemetrexed | Pemetrexed |
0409-1062 | Pemetrexed | Pemetrexed |
0409-2188 | PEMETREXED | PEMETREXED |
0409-3532 | PEMETREXED | PEMETREXED |
0480-4514 | Pemetrexed | Pemetrexed |
0480-4515 | Pemetrexed | Pemetrexed |
0480-4516 | Pemetrexed | Pemetrexed |
0781-3518 | Pemetrexed | Pemetrexed disodium |
0781-3519 | Pemetrexed | Pemetrexed disodium |
0781-3520 | Pemetrexed | Pemetrexed disodium |
16729-229 | Pemetrexed | Pemetrexed |
16729-230 | Pemetrexed | Pemetrexed |
16729-244 | Pemetrexed | Pemetrexed |
16729-522 | Pemetrexed | Pemetrexed disodium |
50742-340 | Pemetrexed | Pemetrexed disodium |
50742-341 | Pemetrexed | Pemetrexed disodium |
55150-381 | Pemetrexed | Pemetrexed |
55150-382 | Pemetrexed | Pemetrexed |
42367-531 | Pemfexy | pemetrexed |